Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous adipose-derived mesenchymal stem cell gel plus high tibial osteotomy for knee cartilage damage
ChiCTR1800017269Phase 2Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Oct 2018
- Modality
- Recombinant Proteins and Enzymes, Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous adipose-derived mesenchymal stromal cells and sodium hyaluronate in knee osteoarthritis (OA) and cartilage defect (2 arms), sponsored by Qilu Hospital of Shandong University. Started Oct 2018; status: recruiting.
02
Drugs
autologous adipose-derived mesenchymal stromal cellssodium hyaluronate
03
Conditions
knee osteoarthritis (OA)cartilage defect
Beyond the preview
Go deeper on ChiCTR1800017269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017269.